secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001041024-25-000009
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical Q2 2025 revenue drops 38% to $16.1M, net loss of $1.5M
-----------------------------------------------------------------------

- Net sales $16.1M, down 38% YoY, driven by loss of largest customer; gross margin 16% in line with guidance.
- Net loss $1.5M vs net income $0.3M in Q2 2024; Adjusted EBITDA -$0.2M vs $1.4M year ago.
- Cash & investments increased to $18.4M, supported by $1.8M operating cash flow.
- Reaffirmed 2025 guidance: net sales $65-70M, gross margin 16-18%, Adj EBITDA -$0.5M to $0.5M.
- Secured multi-year supply agreements with Innovative Renal Care (3-yr) and other providers; >80% customers under long-term contracts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000104102425000009/0001041024-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000104102425000009/rmti-20250814.htm
  HTML page:      https://secwatch.observer/filing/0001041024-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer